Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monitoring Azathioprine Metabolites and Cytokines in NMOSD
NCT05896605Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azathioprine in Neuromyelitis Optica Spectrum Disorder (NMOSD), sponsored by The First Affiliated Hospital of Guangxi Medical University. Started Jan 2020; status: completed.
02
Drugs
azathioprine
03
Conditions
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Beyond the preview
Go deeper on NCT05896605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05896605.